NDC 16729-367-45 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-367
- Requested NDC
- 16729-367-45
- Package NDCs from labels
- 16729-367-10, 16729-367-15, 16729-367-16, 16729-367-17, 16729-367-45, 16729-367-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2024-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-367-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-367-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-367-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-367-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-367-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-367-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-367-10 | EA - Each | 16729-367 | aea7451f-249f-4002-a7df-f367e3bb0513 | 1 | 2020-09-14 |
| 16729-367-15 | EA - Each | 16729-367 | 0eff996a-5135-4a4b-a09e-70ccc66334d4 | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f331769a-ff11-6c68-e053-2a95a90a493b | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db4d84ce-cf51-61dc-e053-2a95a90a2cfd | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2b94985-c79d-40e3-e053-2a95a90a0d78 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | c97e38f2-7163-4d4e-a694-4d0612423e53 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f2f3b60a-bffe-2675-e053-2995a90ae96e | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f7091c54-0984-7f6e-e053-6394a90afb4d | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f68d211d-d802-6c78-e053-2995a90a90d7 | 2026-01-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 3984e6b9-2d88-47f0-af09-cce428bba14f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | db895e64-3f97-9201-e053-2a95a90ac7ef | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Solco Healthcare US, LLC | bdca31d3-60b1-4659-aef7-56530b4f9039 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 403855 403853 403854 0J48LPH2TH 6M97XTV3HD |
| Youth Glow Vitamin C CC Cream Sunscreen SPF 50 - Fair | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 47428cd4-fbad-ba7a-e063-6394a90a1c5c | 2025-12-31 | Warnings | 15FIX9V2JP |
| Youth Glow Vitamin C CC Cream Sunscreen SPF 50 - Medium | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 47433a62-91e0-b031-e063-6294a90a0d49 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Fair | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 4743b6a9-4d79-1b2b-e063-6394a90a9710 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Light Medium | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 4744e501-f12a-6d25-e063-6394a90a2574 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Medium | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 47456bf5-9f6c-e6a5-e063-6294a90a7054 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Tan | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 4745ab56-abaa-42de-e063-6394a90a6310 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Tan Deep | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 4745ebec-acb0-77c4-e063-6394a90aee07 | 2025-12-31 | Warnings | 15FIX9V2JP |
| Radiant Glow Illuminating BB Cream Sunscreen SPF 30 - Deep | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | Pur-lisse Beauty, LLC | 47461ad3-a11e-2a11-e063-6294a90a0f8f | 2025-12-31 | Warnings | 15FIX9V2JP |
| Dermagesic | PRAMOXINE HCL, ZINC OXIDE, CALAMINE | Llorens Pharmaceutical International Division | bbff6b53-29da-45c1-8ccd-3e9df7f250e0 | 2025-12-31 | Warnings | 1K09F3G675 |
| Sei Bella CC Brightening Creme Light | OCTINOXATE 7.5%, TITANIUM DIOXIDE 5%, ZINC OXIDE 1% | Melaleuca Inc. | 6894b9d9-a5b5-4c98-e053-2991aa0a9ca2 | 2025-12-31 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.